Navigation Links
Study Confirms It: Booze Impairs Decision-Making
Date:10/19/2010

TUESDAY, Oct. 19 (HealthDay News) -- A new study confirms what many people may know first- or secondhand: Too much alcohol slows reaction time and increases errors during decision-making.

Specifically, the researchers found that alcohol affects certain brain regions involved in error processing more than others.

The study included 38 volunteers who received no alcohol (control group) or different doses of alcohol in order to make them either moderately or highly intoxicated.

They then took a reaction test, which found no significant difference between the control group and those who were moderately drunk. However, the highly intoxicated volunteers had slower reaction time and more errors than the control group.

The study appears online and in the January print issue of the journal Alcoholism: Clinical & Experimental Research.

"Alcohol is widely consumed in our society today. We know it alters behavior, but surprisingly it is not well studied at the brain level. Once we understand how it is altering the brain, we can better inform the public of the consequences of drinking alcohol," lead author Beth Anderson, a postdoctoral fellow at the Olin Neuropsychiatry Research Center at Hartford Hospital in Connecticut, said in journal news release.

More information

The U.S. National Institute on Alcohol Abuse and Alcoholism has more about alcohol and your health.

-- Robert Preidt

SOURCE: Alcoholism: Clinical & Experimental Research, news release, Oct. 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Low Testosterone May Raise Risk of Early Death: Study
2. Binge Drinking, Pot Could Put Teens Intellect at Risk: Study
3. Fish Oil Pills Dont Affect Postpartum Depression: Study
4. Study reveals superior sedation method for children
5. Surgery on Wrong Patients, Surgical Sites Persists, Study Finds
6. Web Site for Hospital Comparisons Is Faulty: Study
7. Penn study gives hope for new class of Alzheimers disease drugs
8. Soy May Reduce Breast Cancer Recurrence: Study
9. Kids Medicaid-Covered Flu Shots Put Docs at a Loss: Study
10. Young Kids Easily Trust What Theyre Told: Study
11. Genomic Systems announces moratorium on studying and treating terminal cancer has ended
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Confirms It: Booze Impairs Decision-Making
(Date:4/24/2017)... ... April 24, 2017 , ... ... individuals with HIV because it is not known to have significant interactions with ... effects to both lower cholesterol levels and dampen inflammation in the bloodstream. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: ... “Reflections of God’s Work” is the creation of published author, Jerri Broglin, a survivor ... , “I believe this a great eye-opener for those searching for answers, as ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami Periodontist ... 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held ... its annual Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda ... generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced ... device as the product advances towards regulatory and clinical phases. , "This is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: